本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Oncolytics Biotech Inc

0.9768
+0.03213.40%
盤前0.9767-0.0001-0.01%08:38 EST
成交量:39.93萬
成交額:38.74萬
市值:1.04億
市盈率:-3.42
高:0.9882
開:0.9500
低:0.9402
收:0.9447
52周最高:1.51
52周最低:0.3258
股本:1.06億
流通股本:9,362.53萬
量比:0.48
換手率:0.43%
股息:- -
股息率:- -
每股收益(TTM):-0.2855
每股收益(LYR):-0.2881
淨資產收益率:-769.06%
總資產收益率:-111.21%
市淨率:1246.69
市盈率(LYR):-3.39

資料載入中...

2025/08/28

SEC問詢函

Form CORRESP - Correspondence
2025/03/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/06/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/03

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/03

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/05

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/05

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/05

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/24

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/06

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/27

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]